Skip to content

Vivident

Active
Private limited companyfounded 2023active for 3 yearsKempische steenweg 175A, 3500 Hasselt, BelgiumKBO/BCE: BE 0803.673.902
Summary

Vivident has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €279,900 and a net result of €123,048. Equity has been growing by about 67% per year since 2023. Its solvency ranks better than 68% of 20,706 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Overview

Official details

Source: KBO
Status
Active since 06-07-2023 Normal situation
Activity
Dental practice NACE 86230and 1 other
Establishment unit
2.347.091.677 3500 Hasselt, since 06-07-2023
Financial year end
31 December
Peppol
Reachable since 28-10-2025

Board and ownership

Financial position

98 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€167,945
▲ 45.5%
Turnover
≈ €420,000
estimated
Profit
€123,048
▲ 40.9%
Equity
€279,900
▲ 78.4%
Total assets
€355,225
▲ 96.0%
Score breakdownraises risk1 change of registered office in 24 monthslowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 6.77, cash €172,944Figures for financial year 2025 (filed on 13-07-2026)Show the evidence

Checked score

Score 2025
98 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 84% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 100=
equity 78.8% of total assets
Liquidity 98=
short-term debt 13.1% · cash 48.7%
Profitability 100=
return on assets 34.6%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,168 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1%lowest value 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025highest value 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €25,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 6.77 (6.91 in 2024), above the usual 1.5. Short-term debt is 13.1% and cash 48.7% of total assets. 21.2% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 87% on liquidity, 80% on profitability and 87% on growth.

The bankruptcy probability was computed on 03-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 6.77, cash €172,944
NBB · annual accounts
raises risk · 1 change of registered office in 24 months
Belgian Official Gazette
lowers risk · Figures for financial year 2025 (filed on 13-07-2026)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 13-07-2026, 18 days ahead of the deadline.
NBB · 3 filings
Deviation from the deadline
2025
18 days early
2024
31 days early
2023
7 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 3 accounts on average 19 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 13 July (3 of the last 3 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
04-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2023.
KBO publications

Financials

Financials · financial year 2025, micro format

Annual accounts 2025 filed on 13-07-2026 at the NBB all 3 filings

Turnover
≈ €420,000
Estimated: probably between €300,000 and €480,000
Total assets
€355,225▲ 96.0%
2024 · €181,253
Net result
€123,048▲ 40.9%
2024 · €87,309
Working capital
€267,895▲ 85.6%
2024 · €144,313
Multi-year overview
2023 to 2025, 3 financial years
Operating result
€157,584
▲ 42.9% 2025
20232025
Net result
€123,048
▲ 40.9% 2025
middle half of the sector
20232025
Equity
€279,900
▲ 78.4% 2025
middle half of the sector
20232025
Total assets
€355,225
▲ 96.0% 2025
middle half of the sector
20232025
Debt
€75,326
▲ 209% 2025
20232025
Working capital
€267,895
▲ 85.6% 2025
highest quarter of the sector
20232025
Solvency
78.8%
▼ 7.7pp 2025
middle half of the sector
20232025
Current ratio
6.77
▼ 0.14 2025
highest quarter of the sector
20232025
Return on assets (ROA)
34.6%
▼ 13.5pp 2025
middle half of the sector
20232025
Every figure per financial year
Every figure with its change against the financial year before
favourable unfavourable
Line202320242025
Operating result€80,449-€110,288▲ 37.1%€157,584▲ 42.9%
Net result€64,542within the sector's middle half-€87,309within the sector's middle half▲ 35.3%€123,048within the sector's middle half▲ 40.9%
Equity€69,542within the sector's middle half-€156,851within the sector's middle half▲ 126%€279,900within the sector's middle half▲ 78.4%
Total assets€114,491below the sector's middle half-€181,253within the sector's middle half▲ 58.3%€355,225within the sector's middle half▲ 96.0%
Debt€44,949-€24,402▼ 45.7%€75,326▲ 209%
Working capital€56,036within the sector's middle half-€144,313within the sector's middle half▲ 158%€267,895above the sector's middle half▲ 85.6%
Solvency60.7%within the sector's middle half-86.5%above the sector's middle half▲ 25.8pp78.8%within the sector's middle half▼ 7.7pp
Current ratio2.25within the sector's middle half-6.91within the sector's middle half▲ 4.676.77above the sector's middle half▼ 0.14
Return on assets (ROA)56.4%above the sector's middle half-48.2%above the sector's middle half▼ 8.2pp34.6%within the sector's middle half▼ 13.5pp
above within below The sector band is the middle half of the companies in Human health activities (NACE 86). A quarter of them sit below it, a quarter above. Each year counts only accounts in the same format, and only where there are at least 30.

The operating result for 2025 is 43% higher than in 2024 and the highest since 2023. It is the second rise in a row.

Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.

Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €355,225
Fixed assets €40,925 ▲ 278%
Current assets €314,300 ▲ 86.3%
Equity and liabilities €355,225
Equity €279,900 ▲ 78.4%
Debt €75,326 ▲ 209%
Debt's share of the balance-sheet total rises from 13.5% to 21.2%. Equity and debt are higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€160,703▲
2024 · €115,120
Cash flow
€126,167▲
2024 · €92,141
Debt to equity
0.27▲
2024 · 0.16
ROE
44.0%▼
2024 · 55.7%
Interest coverage
over 100
2024 · over 100
Debt ≤ 1 year
€46,405▲
2024 · €24,402
Debt > 1 year
€28,920
Income taxes
€36,261▲
2024 · €23,319
Green means a favourable move, even when the figure itself falls, as with debt or debt to equity.

Investments

fixed assets acquired
Item202320242025
Tangible fixed assets€10,000€3,863€38,990
Depreciation and write-downs of the year€1,125€4,832€3,119

Source: notes to the 2023 to 2025 annual accounts (statement of fixed assets)

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 42 lines
Balance sheet Code20242025
Assets
Total assets20/58€181,253€355,225▲
Formation expenses20€1,705-
Fixed assets21/28€10,833€40,925▲
Tangible fixed assets22/27€10,833€40,925▲
Furniture and vehicles24€10,833€40,925▲
Current assets29/58€168,715€314,300▲
Amounts receivable within one year40/41€11,307€15,503▲
Trade receivables40€122€1,274▲
Other amounts receivable41€11,185€14,230▲
Current investments50/53-€102,000
Cash at bank and in hand54/58€134,525€172,944▲
Deferred charges and accrued income490/1€22,883€23,854▲
Equity and liabilities
Total equity and liabilities10/49€181,253€355,225▲
Equity10/15€156,851€279,900▲
Contributions10/11€5,000€5,000=
Reserves13€151,851€274,900▲
Distributable reserves133€151,851€274,900▲
Amounts payable17/49€24,402€75,326▲
Amounts payable after more than one year17-€28,920
Financial debts170/4-€28,920
Amounts payable within one year42/48€24,402€46,405▲
Current portion of amounts payable after more than one year42-€9,307
Trade debts44€1,173€1,448▲
Suppliers440/4€1,173€1,448▲
Taxes, remuneration and social security45€23,229€35,649▲
Taxes450/3€23,229€35,649▲
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€4,832€3,119▼
Other operating charges640/8€342€257▼
Non-recurring operating charges66A-€6,985
Gross operating margin9900€115,462€167,945▲
Operating profit (loss)9901€110,288€157,584▲
Financial income75/76B€469€1,931▲
Recurring financial income75€469€1,931▲
Financial charges65/66B€128€206▲
Recurring financial charges65€128€206▲
Profit (loss) for the period before taxes9903€110,629€159,309▲
Income taxes67/77€23,319€36,261▲
Profit (loss) for the period9904€87,309€123,048▲
Profit (loss) for the period to be appropriated9905€87,309€123,048▲
Appropriation of the result
Profit (loss) to be appropriated9906€87,309€123,048▲
Transfer to equity691/2€87,309€123,048▲
To other reserves6921€87,309€123,048▲

The notes to these accounts have 9 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.

Source: Annual accounts 2025 at the NBB, filed on 13-07-2026.

Line202320242025Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1,125€4,832€3,119▼ 35.5%
Other operating charges640/8€168€342€257▼ 24.9%
Non-recurring operating charges66A--€6,985-
Gross operating margin9900€81,742€115,462€167,945▲ 45.5%
Operating profit (loss)9901€80,449€110,288€157,584▲ 42.9%
Financial income75/76B€743€469€1,931▲ 312%
Recurring financial income75€743€469€1,931▲ 312%
Financial charges65/66B€18€128€206▲ 60.5%
Recurring financial charges65€18€128€206▲ 60.5%
Profit (loss) for the period before taxes9903€81,174€110,629€159,309▲ 44.0%
Income taxes67/77€16,631€23,319€36,261▲ 55.5%
Profit (loss) for the period9904€64,542€87,309€123,048▲ 40.9%
Profit (loss) for the period to be appropriated9905€64,542€87,309€123,048▲ 40.9%
Line202320242025Change
Assets
Total assets20/58€114,491€181,253€355,225▲ 96.0%
Formation expenses20€4,022€1,705--
Fixed assets21/28€9,485€10,833€40,925▲ 278%
Tangible fixed assets22/27€9,485€10,833€40,925▲ 278%
Furniture and vehicles24€9,485€10,833€40,925▲ 278%
Current assets29/58€100,984€168,715€314,300▲ 86.3%
Amounts receivable within one year40/41€32€11,307€15,503▲ 37.1%
Trade receivables40€32€122€1,274▲ 940%
Other amounts receivable41-€11,185€14,230▲ 27.2%
Current investments50/53--€102,000-
Cash at bank and in hand54/58€84,189€134,525€172,944▲ 28.6%
Deferred charges and accrued income490/1€16,763€22,883€23,854▲ 4.2%
Equity and liabilities
Total equity and liabilities10/49€114,491€181,253€355,225▲ 96.0%
Equity10/15€69,542€156,851€279,900▲ 78.4%
Contributions10/11€5,000€5,000€5,000=
Reserves13€64,542€151,851€274,900▲ 81.0%
Distributable reserves133€64,542€151,851€274,900▲ 81.0%
Amounts payable17/49€44,949€24,402€75,326▲ 209%
Amounts payable after more than one year17--€28,920-
Financial debts170/4--€28,920-
Amounts payable within one year42/48€44,949€24,402€46,405▲ 90.2%
Current portion of amounts payable after more than one year42--€9,307-
Trade debts44€2,270€1,173€1,448▲ 23.5%
Suppliers440/4€2,270€1,173€1,448▲ 23.5%
Taxes, remuneration and social security45€22,747€23,229€35,649▲ 53.5%
Taxes450/3€22,747€23,229€35,649▲ 53.5%
Other amounts payable47/48€19,931---
Line202320242025Change
Profit (loss) for the period9904€64,542€87,309€123,048▲ 40.9%
+ Depreciation and write-downs630€1,125€4,832€3,119▼ 35.5%
Operating cash flow (approximation)€65,668€92,141€126,167▲ 36.9%
Investment in fixed assets (approximation)--€6,180-€33,210▼ 437%
Change in cash-€50,336€38,419▼ 23.7%

A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.

Download as CSV

Historical observation

In July 2024, 39,278 companies had the same profile as Vivident has now. Two years later, 95.8% were still going and 1.8% had gone bankrupt.

  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
95.8% was still going
2.3% stopped otherwise
1.8% went bankrupt

Another 0.1% stopped without a precise date, possibly only after those two years.

The bankruptcy probability of Vivident itself is lower: < 0.1% within 12 months. It rests on far more data about Vivident than the profile alone.

Test of the method

The method was tested on the 497,446 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,278 companies, not a prediction for Vivident. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Filings with the National Bank (3)
Financial year Type Filed Reference Document
31-12-2025 micro format 13-07-2026 2026-00294865 PDF
31-12-2024 micro format 30-06-2025 2025-00196766 PDF
31-12-2023 micro format 24-07-2024 2024-00286560 PDF

Board & ownership

Directors

Directors
1 director, no change since 2023
MAAT Vivian Hubertina Petra
Director (not named in the articles) · appointed in the act of 10-07-2023 · term without a fixed end · listed in the 2025 annual accounts, filed on 13-07-2026
Current
Signing authorityThe articles say who may bind the company, for example by signing a contract.
Each director alone
deed of 10-07-2023

Owners and capital

Shareholders

At incorporation act of 10-07-2023 ↗

Capital transactions

Capital over time
  1. 10-07-2023 Incorporation · €5,000 · 100 shares

Articles of association

Statutory auditorA statutory auditor is a registered auditor who checks the annual accounts. Small companies need not have one. According to the deed, the legal criteria do not require one here.
No statutory auditor

Articles of association, deed of 10-07-2023 (in Dutch)

Network & group

Vivident shares no director with another company.

Companies at the same address

1 other company

Connections & network

1 current director
Depth

The network starts from the directors of Vivident. Every other company they run is a node.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.

Timeline

Acts, filings and financial milestones

Deadline for the 2026 accounts: 31-07-2027
2026
13-07
NBB filing Annual accounts 2025 filedNBB
micro format · 18 days before the deadline
2025
31-12
Financial Highest result from 2023 to 2025net €123,048 ▲40.9%
The operating result of €157,584 and the net result of €123,048 are both a record.
31-12
Financial Equity above €200,000equity €279,900 ▲78.4%
With a profit in every financial year since 2023, equity grows to €279,900.
30-06
NBB filing Annual accounts 2024 filedPDF
micro format · 31 days before the deadline
2024
31-12
Financial Liquidity more than triplescurrent ratio 6.91
The current ratio rises from 2.25 to 6.91. Short-term debt falls from €44,949 to €24,402.
31-12
Financial Equity above €150,000equity €156,851 ▲126%
With a profit in every financial year since 2023, equity grows to €156,851.
16-12
Gazette deed Registered office moved from Genk to Hasselt
New seat: 3500 Hasselt, Kempische Steenweg 175A bus 0.01 · Previous seat: 3600 Genk, Collegelaan 122 points ▸
  • Board meeting, 04-11-2024
  • Registered-office move, 3500 Hasselt,Kempische Steenweg 175A bus 0.01

Open the act in the Belgian Official Gazette

24-07
NBB filing Annual accounts 2023 filedPDF
micro format · 7 days before the deadline
2023
10-07
Gazette deed Incorporation
Starting capital €5,000 · Appointment: MAAT Vivian Hubertina Petra (director) · Registered office clause · Board rule10 points ▸
  • Other provision, “slot- en overgangsbepalingen-uitwerking, overeenkomstig de wet” (deed in Dutch)
  • Registered office clause, “3600 Genk,Collegelaan 12” (deed in Dutch)
  • Board rule, 1
  • Director appointment, MAAT Vivian Hubertina Petra (director (not named in the articles))
  • Pre-incorporation commitments, “takeover, alle verbintenissen en verplichtingen en alle activiteiten in naam en voor rekening van vennootschap in oprichting” (deed in Dutch)
  • Incorporation, “VIVIDENT” (deed in Dutch)
  • Founding capital, €5,000
  • Founder, MAAT Vivian Hubertina Petra
  • Other provision, “heden, financieel plan” (deed in Dutch)
  • Other provision, “bepalingen van het Wetboek van vennootschappen en verenigingen, bevestiging deponering” (deed in Dutch)

Open the act in the Belgian Official Gazette

Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.

Sources:Publications in the Belgian Official GazetteFilings with the National Bank

History

On 6 July 2023, Vivident was incorporated as a private limited company by one natural person, with a starting capital of €5,000.12 In 2024 the registered office moved to Hasselt.3 MAAT Vivian Hubertina Petra is director of the company, appointed in the act of 10-07-2023.2 Total assets went from €114,491 in 2023 to €355,225 in 2025.4

  1. 1KBO register
  2. 2Belgian Official Gazette, 10-07-2023
  3. 3Belgian Official Gazette, 16-12-2024
  4. 4National Bank, annual accounts 2023 and 2025

Company details

Register details

Identity

KBO record
Name Vivident in Dutch
Enterprise number 0803.673.902
Legal form Private limited company
Status Active, normale toestand
Founded 06-07-2023
Entity type Legal entity
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 10-07-2023 (in Dutch)
Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
“Vlaamse Gewest, Artikel 2”
deed of 10-07-2023 (in Dutch)

Registered office and establishments

Registered office Kempische steenweg 175A, 3500 Hasselt, Belgium
1 former office
  • 3600 Genk until 04-11-2024 · act of 16-12-2024
Establishment unit Vivident, Kempische steenweg 175A, 3500 Hasselt since 06-07-2023 · unit number 2.347.091.677

Activities

NACEBEL 2025
86230 Dental practice main activity
96220 Beauty care and other beauty treatments
Codes under NACEBEL 2008
86230 Human health activities main activity
96022 Beauty treatment
PurposeThe purpose describes the activities the company may carry out under its articles.
“Het faciliteren van het uitbaten en het uitbaten van tandartspraktijken en alle bijhorigheden ervan met inbegrip van tandtechnische labo's…”
18 activities
  1. Het faciliteren van het uitbaten en het uitbaten van tandartspraktijken en alle bijhorigheden ervan met inbegrip van tandtechnische labo's evenals het uitvoeren van alle activiteiten ermee verband houdend zoals onder meer inzake opleiding onderzoek dienstverlening en consultancy alsook de aan-en verkoop de verhuring de huur(koop) van producten materialen en apparatuur die rechtstreeks of onrechtstreeks ermee verband houden
  2. Het verlenen van adviezen van financiële technische commerciële of administratieve aard in de ruimste zin bijstand en diensten verlenen rechtstreeks of onrechtstreeks op het vlak van administratie en financiën verkoop productie en algemeen bestuur De verrichtingen die door de wet van vijfentwintig oktober tweeduizend zestien zijn voorbehouden aan de beleggingsdienstenbedrijven en de beleggingsadviseurs zijn de vennootschap verboden
  3. Het beheer van een onroerende of roerend vermogen en de huur-financiering van roerende en onroerende goederen aan derden het aankopen verkopen ruilen doen bouwen doen verbouwen onderhouden verhuren huren verkavelen prospecteren en uitbaten van onroerende goederen alsmede alle handelingen die rechtstreeks of onrechtstreeks met dit voorwerp in verband staan en die van aard zijn de opbrengst van de onroerende goederen te bevorderen
  4. Onderneming in onroerende goederen welke ondermeer omvat:i)de verwerving de vervreemding de inleasinggeving het beheer de uitbating de valorisatie de verkaveling de ordening het huren en verhuren het doen bouwen en het verbouwen van onroerende goederen en desgevallend met het oog op overdracht aan derden–hetzij verkoop op plan hetzij verkoop als gebouw hetzij verhuur hetzij het verlenen van zakelijke rechten hetzij in leasing geven
  5. Ii)tussenhandelaar de makelarij en/of handel in de onroerende goederen dit in de meest ruime zin van het woord met inbegrip van onroerende leasing met uitsluiting evenwel van handelingen welke vallen onder de beroepswerkzaamheden van vastgoedmakelaar zoals bepaald in het koninklijk besluit de dato 06/09/1993 tot bescherming van de beroepstitel en van de uitoefening van het beroep van vastgoedmakelaar
  6. Iii)het nemen en afstaan van optierechten terzake het kopen van onroerende goederen of immobiliënvennootschappen alsmede de uitgifte van vastgoedcertificaten
  7. Het verwerven door inschrijving of aankoop en het beheren van aandelen obligaties of andere roerende waarden van welke vorm ook van Belgische of buitenlandse bestaande of nog op te richten vennootschappen
  8. De verwerving voor eigen rekening van eender welke titels rechten of roerende waarden door middel van participatie inbreng onderschrijving intekening plaatsing waarborg koop aankoopoptie verhandeling of op iedere andere wijze
  9. Het aangaan en afsluiten van leningen kredieten en financieringen alsmede het verstrekken van leningen kredieten en financieringen aan vennootschappen particulieren organisaties derden al dan niet gelieerd in de meest brede zin van het woord
  10. Het doen van studies en onderzoek het uitvoeren van analyses het verstrekken van adviezen het voorstellen en implementeren van oplossingen en aanverwante diensten
  11. De organisatie van allerlei evenementen
  12. Uitvoering van alle werken die met voormelde activiteiten rechtstreeks of onrechtstreeks in verband staan zonder enige beperking
  13. Alle verrichtingen uitvoeren die nodig of nuttig zijn voor de verwezenlijking van haar voorwerp activiteiten uitbreiden tot alle takken die aanverwant zijn met de hiervoor vermelde goederen en diensten
  14. In het algemeen alle commerciële industriële financiële roerende of onroerende handelingen verrichten in rechtstreeks of onrechtstreeks verband met haar voorwerp of welke van aard zouden zijn de verwezenlijking ervan geheel of ten dele te vergemakkelijken dit zowel in België als in het buitenland
  15. Bij wijze van inbreng in speciën of in natura van fusie inschrijving deelneming financiële tussenkomst of op een andere wijze een aandeel nemen in alle bestaande of op te richten vennootschappen of bedrijven in België of het buitenland waarvan het voorwerp identiek gelijkaardig of verwant is met het hare of van aard is de uitoefening van haar voorwerp te bevorderen
  16. Zekerheden stellen zowel tot waarborg van eigen verbintenissen als tot waarborg van verbintenissen van derden waarbij zij zich borg kan stellen dan wel zakelijke zekerheden vestigen zoals onder andere–doch zonder beperkt te zijn tot-haar goederen in hypotheek of in pand te geven inclusief de eigen handelszaak
  17. Zelf of als tussenpersoon alle hulpmiddelen verschaffen bestuurdersfuncties waarnemen of laten waarnemen en diensten verlenen die direct of indirect verband houden met haar voorwerp Deze diensten kunnen worden geleverd krachtens een contractuele of statutaire benoeming en in de hoedanigheid van externe raadgever of orgaan van de cliënt Ter uitvoering van haar opdrachten en voor het waarnemen van bestuursmandaten kan de vennootschap zich laten vertegenwoordigen door haar bestuurder of elke andere derde vertegenwoordiger die door de vennootschap worden afgevaardigd om op te treden in eigen naam doch voor rekening van de vennootschap
  18. Optreden als volmachtdrager mandataris of vereffenaar in andere vennootschappen of ondernemingen
deed of 10-07-2023 (in Dutch)

Invoicing and payment

VAT number BE 0803.673.902
E-invoicing via Peppol
Reachable via Peppol
Peppol ID 0208:0803673902
Other Peppol ID 9925:BE0803673902
Registered 28-10-2025

Follow this company and you will hear the next morning if it leaves the Peppol register.

Register as of 4 November 2026 · Peppol Directory

Financial year and general meeting

Accounts at the NBB
Financial year end 31-12
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Last Thursday of June at 17:00
deed of 10-07-2023 (in Dutch)

Sites & property

Location
registered office establishment The establishment unit on the map
2 companies at this address See who is registered here

Buildings and parcels at the address

Ground area
1,448 m²
Building footprint
452 m²
Building volume
1,192 m³
Cadastral parcel Region Area Buildings Height / floors
71322A0511/00K004 Flanders 1,448 m² 1 · 452 m² 10.5 m